Episode 130 - Bethany & Mike Smilovitch - How Precision Medicine Helped Save His Life from Stage 4 Cancer

Listen To The Episode


Meet Bethany & Mike Smilovitch

MEET THE GUESTS

Michael Smilovitch & Bethany Smilovitch, Co-Founders

Michael and Bethany Smilovitch are entrepreneurs, investors, and passionate advocates for families navigating cancer. After Michael was diagnosed with Stage IV melanoma and given a terminal prognosis, the couple traveled worldwide in search of treatment, ultimately finding a T-cell therapy that changed the course of his disease. Drawing on their experience in healthcare, wellness, consumer brands, and business, they now dedicate their work to helping others access hope, navigate cancer, and find better paths forward, all while raising their children, Aston and Scarlett.


What We Talk About

• Mike Smilovich's stage-four melanoma diagnosis and the devastating prognosis he received.
• The early symptoms, including persistent shoulder pain, breathing issues, lumps, fatigue, and bone pain, dismissed as unrelated.
• How seeing multiple specialists without anyone connecting the dots delayed diagnosis.
• The MRI that revealed bone edema and led doctors to investigate cancer.
• Discovering metastatic cancer in Mike's liver, bones, kidneys, spinal cord, and brain.
• The shock of learning the cancer had spread to his cerebrospinal fluid.
• Why building a team of doctors and seeking multiple opinions became critical to their strategy.
• The role of immunotherapy and targeted therapy after discovering Mike's BRAF mutation.
• How targeted medication shrank visible tumors and bought Mike additional time.
• Bethany and Mike's decision to look beyond conventional treatment and contact specialists, researchers, and clinical trial teams worldwide.
• The importance of genomic sequencing in understanding a tumor's specific biology and mutations.
• How Mike's genomic report revealed treatment options that hadn't been considered.
• The discovery of an HLA type that helped identify a life-changing T-cell therapy.
• How persistence and networking helped Mike overcome a clinical trial waitlist and access treatment in Germany.
• What T-cell therapy involved, from extracting and engineering Mike's T cells to reinfusing them.
• The intense side effects Mike experienced, including high fevers, severe pain, low oxygen, and memory loss.
• How Mike's scans and circulating tumor DNA testing monitor his disease for early warning signs.
• Why Mike and Bethany believe patients need to become informed advocates for their own tumor biology and treatment options.
• The role of hope, mindset, survivor stories, and reducing stress during the cancer journey.
• How their experience inspired the Smilo Foundation, helping patients find precision treatment and clinical trial options via medical records, genomic data, expert review, and AI.


Episode Resources

Prenuvo
Full-body MRI scans to catch what standard checkups and scans can miss.
http://prenuvo.com/ERIKA

Thorne
Science-backed supplements to help fill nutritional gaps in your routine.
https://shop.thetrailtohealth.com/Thorne

Therabody
Everyday recovery tools to support muscle relaxation and mobility.
https://shop.thetrailtohealth.com/Therabody

Oura Ring
A smart ring that tracks your sleep and daily readiness over time.
https://shop.thetrailtohealth.com/OuraRing

Vitamix
Powerful blenders for whole-food, nutrient-dense meals made at home.
https://shop.thetrailtohealth.com/vitamix



Keywords

stage four melanoma, cancer diagnosis, precision oncology, genomic sequencing, T-cell therapy, immunotherapy, BRAF mutation, clinical trials, cancer survivor, cerebrospinal fluid cancer, circulating tumor DNA, cancer advocacy, targeted therapy, Smilo Foundation